G
Giuseppe Sangiorgi
Researcher at University of Rome Tor Vergata
Publications - 378
Citations - 21460
Giuseppe Sangiorgi is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Stent & Myocardial infarction. The author has an hindex of 70, co-authored 351 publications receiving 20142 citations. Previous affiliations of Giuseppe Sangiorgi include Mayo Clinic & University of Modena and Reggio Emilia.
Papers
More filters
Journal ArticleDOI
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
Ioannis Iakovou,Thomas Schmidt,Erminio Bonizzoni,Lei Ge,Giuseppe Sangiorgi,Goran Stankovic,Flavio Airoldi,Alaide Chieffo,Matteo Montorfano,Mauro Carlino,Iassen Michev,Nicola Corvaja,Carlo Briguori,Ulrich Gerckens,Eberhard Grube,Antonio Colombo +15 more
TL;DR: The cumulative incidence of stent thrombosis 9 months after successful drug-eluting stent implantation in consecutive "real-world" patients was substantially higher than the rate reported in clinical trials.
Journal ArticleDOI
Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology
Giuseppe Sangiorgi,John A. Rumberger,Arlen R. Severson,William D. Edwards,Jean Grégoire,Lorraine A. Fitzpatrick,Robert S. Schwartz +6 more
TL;DR: Coronary calcium quantification is an excellent method of assessing atherosclerotic plaque presence at individual artery sites and the remodeling phenomenon is the likely explanation for the lack of a good predictive value between lumen narrowing and quantification of mural calcification.
Journal ArticleDOI
Pathology of Acute and Chronic Coronary Stenting in Humans
Andrew Farb,Giuseppe Sangiorgi,Andrew J. Carter,Virginia M. Walley,William D. Edwards,Robert S. Schwartz,Renu Virmani +6 more
TL;DR: Morphology after coronary stenting demonstrates early thrombus formation and acute inflammation followed by neointimal growth, and deployment strategies that reduce medial damage and avoid stent oversizing may lower the frequency of in-stent restenosis.
Journal ArticleDOI
Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary Syndrome The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study
Enrico Romagnoli,Giuseppe Biondi-Zoccai,Alessandro Sciahbasi,Luigi Politi,Stefano Rigattieri,Gianluca Pendenza,Francesco Summaria,Roberto Patrizi,Ambra Borghi,Cristian Di Russo,Claudio Moretti,Pierfrancesco Agostoni,Paolo Loschiavo,Ernesto Lioy,Imad Sheiban,Giuseppe Sangiorgi +15 more
TL;DR: Radial access in patients with ST-segment elevation acute coronary syndrome is associated with significant clinical benefits, in terms of both lower morbidity and cardiac mortality, and should become the recommended approach in these patients, provided adequate operator and center expertise is present.
Journal ArticleDOI
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.
Giuseppe Biondi-Zoccai,Marzia Lotrionte,Pierfrancesco Agostoni,Antonio Abbate,Massimiliano Fusaro,Francesco Burzotta,Luca Testa,Imad Sheiban,Giuseppe Sangiorgi +8 more
TL;DR: Non-compliance or withdrawal of aspirin treatment has ominous prognostic implication in subjects with or at moderate-to-high risk for CAD and aspirin discontinuation in such patients should be advocated only when bleeding risk clearly overwhelms that of atherothrombotic events.